This study is looking at estimate, from a collective point of view, the incremental cost-utility ratio of VNS to treat patients suffering from RD for people with Treatment Resistant Depression. Participants take part in a digital support tool and complete follow-up assessments.
This study is looking at whether Sham-stimulation can help people with Treatment Resistant Depression. Participants take part in Sham-stimulation and complete follow-up assessments.
Multiple locations, including Birmingham
DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 22 Years to 70 Years
This observational study is following people with depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at whether Psilocybin 25 mg can help people with Treatment Resistant Depression or Chronic Pain. Participants take part in Psilocybin 25 mg and complete follow-up assessments.
In Toronto
DepressionDrugA study involving a medication or substance.From 18 Years to 65 Years
This study is looking at whether Patients start with either phenelzine 15 mg or lithiumcarbonate 200 mg can help people with Depression, Mental and Behavioural Disorders, or 1. Depressive episode 2.
In Netherlands
DepressionOther
Countries
Netherlands
Sponsor
Altrecht Mental Health Care (Altrecht Geestelijke Gezondheidszorg [GGZ]) (Netherlands)
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.